[EN] ARYLBENZOISOXAZOLE COMPOUNDS AS IP6K AND IPMK INHIBITORS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS D'ARYLBENZOISOXAZOLE UTILISÉS EN TANT QU'INHIBITEURS D'IP6K ET D'IPMK ET LEURS PROCÉDÉS D'UTILISATION
申请人:[en]THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
公开号:WO2023154466A1
公开(公告)日:2023-08-17
Arylbenzoisoxazole compounds of Formula (II), where R1and R2are defined herein, are useful for inhibiting isoforms of IP6K and IPMK, and for treating diseases and disorders such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), cancer, and viral infections. Methods of using compounds of Formula (II) for prevention or treatment of such diseases and disorders, pharmaceutical compositions comprising the compounds, and methods of preparing the compounds are also disclosed.